Assessment of diastolic function with Doppler tissue imaging to predict genotype in preclinical hypertrophic cardiomyopathy

Circulation

Volumn 105, Issue 25, 2002, Pages 2992-2997

  Ho, Carolyn Y ^a   Sweitzer, Nancy K ^a   McDonough, Barbara ^a   Maron, Barry J ^a   Casey, Susan A ^a   Seidman, J G ^a   Seidman, Christine E ^a   Solomon, Scott D ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Cardiomyopathy; Diastole; Echocardiography; Genetics; Hypertrophy

Indexed keywords

MYOSIN HEAVY CHAIN;

ADULT; ARTICLE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIASTOLE; DOPPLER ECHOCARDIOGRAPHY; ELECTROCARDIOGRAM; FEMALE; GENOTYPE; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; MALE; MUTATION; PRIORITY JOURNAL; VELOCITY;

ADULT; CARDIOMYOPATHY, HYPERTROPHIC, FAMILIAL; DIASTOLE; ECHOCARDIOGRAPHY, DOPPLER; ELECTROCARDIOGRAPHY; FEMALE; GENOTYPE; HUMANS; MALE; MUTATION; MYOSIN HEAVY CHAINS;

EID: 0037173015     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.0000019070.70491.6D     Document Type: Article

References (29)

1. Hypertrophic cardiomyopathy: The importance of the site and the extent of hypertrophy. A review
2. Hypertrophic cardiomyopathy
3. α-tropomyosin and cardiac troponin T mutations cause familial hypertrophic cardiomyopathy: A disease of the sarcomere
4. Mutations in the gene for cardiac myosin-binding protein C and late-onset familial hypertrophic cardiomyopathy
5. Left ventricular hypertrophy and morphology in familial hypertrophic cardiomyopathy associated with mutations of the β-myosin heavy chain gene
6. Preclinical diagnosis of familial hypertrophic cardiomyopathy by genetic analysis of blood lymphocytes
7. Development and progression of left ventricular hypertrophy in children with hypertrophic cardiomyopathy
8. Noninvasive assessment of left ventricular diastolic function by pulsed Doppler echocardiography in patients with hypertrophic cardiomyopathy
9. Diastolic function in hypertrophic cardiomyopathy: Relation to exercise capacity
10. Noninvasive Doppler echocardiographic evaluation of left ventricular filling pressures in patients with cardiomyopathies: A simultaneous Doppler echocardiographic and cardiac catheterization study
11. Relation between extent of left ventricular hypertrophy and diastolic filling abnormalities in hypertrophic cardiomyopathy
12. Exercise capacity in hypertrophic cardiomyopathy depends on left ventricular diastolic function
13. New Doppler echocardiographic applications for the study of diastolic function
14. Doppler tissue imaging: A noninvasive technique for evaluation of left ventricular relaxation and estimation of filling pressures
15. Doppler estimation of left ventricular filling pressures in patients with hypertrophic cardiomyopathy
16. Tissue Doppler imaging consistently detects myocardial contraction and relaxation abnormalities, irrespective of cardiac hypertrophy, in a transgenic rabbit model of human hypertrophic cardiomyopathy
17. Tissue Doppler imaging consistently detects myocardial abnormalities in patients with hypertrophic cardiomyopathy and provides a novel means for an early diagnosis before and independently of hypertrophy
18. Recommendations for quantitation of the left ventricle by two-dimensional echocardiography: American Society of Echocardiography Committee on Standards
19. Two-dimensional echocardiographic calculation of left ventricular mass as recommended by the American Society of Echocardiography: Correlation with autopsy and M-mode echocardiography
20. A mouse model of familial hypertrophic cardiomyopathy
21. The pathogenesis of familial hypertrophic cardiomyopathy: Early and evolving effects from an α-cardiac myosin heavy chain missense mutation
22. Effect of aging on diastolic left ventricular myocardial velocities measured by pulsed tissue Doppler imaging in healthy subjects
23. Pathogenesis of diverse clinical and pathological phenotypes in hypertrophic cardiomyopathy
24. The molecular genetic basis for hypertrophic cardiomyopathy
25. R403Q and L908V mutant β-cardiac myosin from patients with familial hypertrophic cardiomyopathy exhibit enhanced mechanical performance at the single molecule level
26. Single-molecule mechanics of R403Q cardiac myosin isolated from the mouse model of familial hypertrophic cardiomyopathy
27. The genetic basis for cardiomyopathy: From mutation identification to mechanistic paradigms
28. Prevalence of hypertrophic cardiomyopathy in a general population of young adults: Echocardiographic analysis of 4111 subjects in the CARDIA study